Abstract
Background and aim: Whether long-term HBV suppression by nucleos(t)ide analogs (NUC) modifies the course of esophageal varices (EV), a complication that predicts both clinical decompensation and anticipated liver related death in patients with HBV cirrhosis, is currently unknown.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have